Bronchoalveolar lavage as a diagnostic tool

Seminars in Respiratory and Critical Care Medicine

Volumn 28, Issue 5, 2007, Pages 546-560

  Meyer, Keith C ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Bronchoalveolar lavage (BAL); Bronchoscopy; Interstitial lung disease (ILD)

Indexed keywords

ARTICLE; BRONCHOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DNA MICROARRAY; GENETIC ANALYSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNE DEFICIENCY; INTERSTITIAL LUNG DISEASE; LEUKOCYTE; LUNG ALVEOLUS CELL; LUNG DISEASE; LUNG FIBROSIS; LUNG GRAFT REJECTION; LUNG INFILTRATE; LUNG LAVAGE; PEDIATRIC LUNG DISEASE; PRIORITY JOURNAL; PROTEOMICS; RESPIRATORY TRACT INFECTION; THORAX; TREATMENT PLANNING;

BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; HUMANS; LEUKOCYTE COUNT; LUNG DISEASES, INTERSTITIAL; LUNG TRANSPLANTATION; RESPIRATORY TRACT INFECTIONS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35648932994     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-991527     Document Type: Article

References (118)

1. Klech H, Pohl W, eds. Technical recommendations and guidelines for bronchoalveolar lavage (BAL): report of the European Society of Pneumology Task Group on BAL. Eur Respir J 1989;2:561-585
2. Klech H, Hutter C, eds. Clinical guidelines and indications for bronchoalveolar lavage (BAL): report of the European Society of Pneumology Task Group on BAL. Eur Respir J 1990;3:937-969
3. The BAL Co-operative Group Steering Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 1990;141(Suppl 5):S169-S202
4. Klech H, Hutter C, Costabel U, eds. Clinical guidelines and indication for bronchoalveolar lavage (BAL): report of the European Society of Pneumology Task Group on BAL. Eur Respir Rev 1992;2:47-127
5. Haslam PL, Baughman RP, eds. Guidelines for the measurement of acellular components and recommendations for standardization of bronchoalveolar lavage (BAL). Eur Respir Rev 1999;9:25-157
6. American Thoracic Society. Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis 1990;142:481-486
7. Martin TR, Raghu G, Maunder RJ, et al. The effects of chronic bronchitis and chronic air-flow obstruction on lung cell populations recovered by bronchoalveolar lavage. Am Rev Respir Dis 1985;132:254-260
8. Baughman RP, Spencer RE, Kleykamp BO, Rashkin MC, Douthit MM. Ventilator associated pneumonia: quality of nonbronchoscopic bronchoalveolar lavage sample affects diagnostic yield. Eur Respir J 2000;16:1152-1157
9. Dhillon DP, Haslam PL, Townsend PJ, et al. Bronchoalveolar lavage in patients with interstitial lung diseases: side effects and factors affecting fluid recovery. Eur J Respir Dis 1986;68:342-350
10. Costabel U, Guzman J. Effect of smoking on bronchoalveolar lavage constituents. Eur Respir J 1992;5:776-779
11. Meyer KC. Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev 1998;104:169-181
12. Meyer KC, Soergel P. Bronchoalveolar lymphocyte phenotypes change in the normal aging human lung. Thorax 1999;54:697-700
13. Lee BE, Robinson JL, Khurana V, Pang XL, Preiksaitis J, Fox JD. Enhanced identification of viral and atypical bacterial pathogens in lower respiratory tract samples with nucleic acid amplification tests. J Med Virol 2006;78:702-710
14. Hohenthal U, Itälä M, Salonen J, et al. Bronchoalveolar lavage in immunocompromised patients with haematological malignancy: value of new microbiological methods. Eur J Haematol 2005;74:203-211
15. Palacios G, Quan P-L, Jabado OJ, et al. Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis 2007 [12 Jan 2006]. Available from http://www.cdc.gov/EID/13/1/73/htm
16. Chen NH, Liu YC, Tsao TC, et al. Combined bronchoalveolar lavage and polymerase chain reaction in the diagnosis of pulmonary tuberculosis in smear-negative patients. Int J Tuberc Lung Dis 2002;6:350-355
17. Peikert T, Rana S, Edell ES. Safety, diagnostic yield, and therapeutic imiplications of flexible bronchoscopy in patients with febrile neutropenia and pulmonary infiltrates. Mayo Clin Proc 2005;80:1414-1420
18. Ninane V. Bronchoscopic invasive diagnostic techniques in the cancer patient. Curr Opin Oncol 2001;13:236-241
19. Joos L, Chhajed PN, Wallner J, et al. Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients. Respir Med 2007;101:93-97
20. Jain P, Sandur S, Meli Y, Arroliga AC, Stoller JK, Mehta AC. Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest 2004;125:712-722
21. Boersma WG, Erjavec Z, van der Werf TS, de Vries-hosper HG, Gouw ASH, Manson WL. Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL. Respir Med 2007;101:317-325
22. Sternberg RI, Baughman RP, Dohn MN, First MR. Utility of bronchoalveolar lavage in assessing pneumonia in immunosuppressed renal transplant recipients. Am J Med 1993;95:358-364
23. Lehto JT, Anttila VJ, Lommi J, et al. Clinical usefulness of bronchoalveolar lavage in heart transplant recipients with suspected lower respiratory tract infection. J Heart Lung Transplant 2004;23:570-576
24. Meduri GU, Wunderink RG, Leeper KV Jr, Beals DH. Management of bacterial pneumonia in ventilated patients: protected bronchoalveolar lavage as a diagnostic tool. Chest 1992;101:500-508
25. Ioanas M, Ferrer R, Angrill J, Ferrer M, Torres A. Microbial investigation in ventilator-associated pneumonia. Eur Respir J 2001;17:791-801
26. Clec'h C, Jauréguy F, Hamza L, et al. Agreement between quantitative cultures of postintubation tracheal aspiration and plugged telescoping catheter, protected specimen brush, or BAL for the diagnosis of nosocomial pneumonia. Chest 2006;130:956-961
27. The Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006;355:2619-2630
28. Baughman RP, Drent M. Role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med 2001;22:331-341
29. Meyer KC. The role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med 2004;25:637-649
30. Baughman RP. Is bronchoalveolar lavage clinically useful for everyday practice in interstitial lung disease? Con: bronchoalveolar lavage. J Bronchology 1999;6:211-216
31. Raghu G. Is bronchoalveolar lavage clinically useful for everyday practice in interstitial lung disease? Con: bronchoalveolar lavage. J Bronchology 1999;6:217-221
32. Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med 2001;7:255-261
33. Costabel U, Guzman J. Bronchoalveolar lavage. In: Schwartz MI, King TE Jr, eds. Interstitial Lung Disease. Hamilton, ON: BC Decker; 2003:114-133
34. Welker L, Jorres RA, Costabel U, Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 2004;24:1000-1006
35. Drent M, Jacobs JA. Bronchoalveolar lavage. In: Baughman RP, Du Bois RM, Lynch JP III, Wells AU, eds. Diffuse Lung Disease: A Practical Approach. New York: Oxford University Press; 2004:56-64
36. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981;305:429-432
37. Costabel U, Zaiss AW, Guzman J. Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis 1992;9(Suppl 1): 211-214
38. Winterbauer RH, Lammert J, Selland M, et al. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 1993;104:352-361
39. Kantrow SP, Meyer KC, Kidd P, et al. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J 1997;10:2716-2721
40. Auerswald U, Barth J, Magnussen H. Value of CD1 positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X. Lung 1991;169:305-309
41. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994;150:1423-1438
42. Pope-Harman AL, Davis WB, Allen ED, et al. Acute eosinophilic pneumonia: a summary of 15 cases and review of the literature. Medicine (Baltimore) 1996;75:334-342
43. Fontenot AP, Schwarz MI. Diffuse alveolar hemorrhage. In: Schwartz MI, King TE Jr, eds. Interstitial Lung Disease. Hamilton, ON: BC Decker; 2003:632-656
44. Martin RJ, Coalson JJ, Rogers RM, et al. Pulmonary alveolar proteinosis: the diagnosis by segmental lavage. Am Rev Respir Dis 1980;121:819-825
45. Joint Statement of the American Thoracic Society (ATS). Idiopathic pulmonary fibrosis: diagnosis and treatment: international consensus statement. Am J Respir Crit Care Med 2000;161:646-664
46. Hunninghake GW, Lynch DA, Galvin JR, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003;124:1215-1223
47. Lynch DA, Godwin D Jr, Safrin S, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005; 172:488-493
48. Shah PL, Hansell D, Lawson PR, Reid KB, Morgan C. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax 2000;55:67-77
49. Haslam PL, Dewar A, Butchers P, et al. Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis: comparison with other interstitial lung diseases. Am Rev Respir Dis 1987;135:35-47
50. Drent M, van Velzen Blad H, Diamant M, et al. Bronchoalveolar lavage in extrinsic allergic alveolitis: effect of time elapsed since antigen exposure. Eur Respir J 1993; 6:1276-1281
51. Lynch JPD, Standiford TJ, Rolfe MW, et al. Neutrophilic alveolitis in idiopathic pulmonary fibrosis: the role of initerleukin-8. Am Rev Respir Dis 1992;145:1433-1439
52. Haslam PL, Turton CW, Lukoszek A, et al. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax 1980;35:328-339
53. Rudd RM, Haslam PL, Turner-Warwick M. Cryptogenic fibrosing alveolitis: relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 1981;124:1-8
54. Watters LC, Schwarz MI, Cherniack RM, et al. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987;135:696-704
55. Peterson MW, Monick M, Hunninghake GW. Prognostic role of eosinophils in pulmonary fibrosis. Chest 1987;92:51-56
56. Drent M, Macobs JA, de Vries J, et al. Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Respir J 1999;13:1338-1344
57. Schwartz DA, Helmers RA, Galvin JR, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994;149:450-454
58. Ryu YJ, Chung MP, Han J, et al. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias. Respir Med 2007;101:655-660
59. De Vuyst P, Dumortier P, Moulin E, et al. Asbestos bodies in bronchoalveolar lavage reflect lung asbestos body concentration. Eur Respir J 1988;1:362-367
60. Dodson RF, Garcia JG, O'Sullivan M, Corn C, et al. The usefulness of bronchoalveolar lavage in identifying past occupational exposure to asbestos: a light and electron microscopy study. Am J Ind Med 1991;19:619-628
61. Fireman E, Greif J, Schwarz Y, et al. Assessment of hazardous dust exposure by BAL and induced sputum. Chest 1999;115:1720-1728
62. Perna F, Iavarone M, Skrimpas S, Mazzarella G, Sanduzzi A. Detection and qualitative identification of mineral fibers and particles in alveolar macrophages of BAL fluid by SEM and EDXA. Monaldi Arch Chest Dis 2002;57:193-195
63. Christman JW, Emerson RJ, Graham WG, Davis GS. Mineral dust and cell recovery from the bronchoalveolar lavage of healthy Vermont granite workers. Am Rev Respir Dis 1985;132:393-399
64. Michetti G, Mosconi G, Zanelli R, et al. Bronchoalveolar lavage and its role in diagnosing cobalt lung disease. Sci Total Environ 1994;150:173-178
65. Rossman MD, Kern JA, Elias JA, et al. Proliferative response of bronchoalveolar lymphocytes to beryllium: a test for chronic beryllium disease. Ann Intern Med 1988;108: 687-693
66. Lam B, Wong MP, Ooi C, et al. Diagnostic yield of bronchoscopic sampling methods in bronchial carcinoma. Respirology 2000;5:265-270
67. Wongsurakiat P, Wongbunnate S, Dejsomritrutai W, et al. Diagnostic value of bronchoalveolar lavage and postbronchoscopic sputum cytology in peripheral lung cancer. Respirology 1998;3:131-137
68. Tang CC, Hsiao CJ, Chen H, et al. Value of bronchoalveolar lavage combined with transbronchial lung biopsy in the diagnosis of peripheral lung cancer. Chang Gung Med J 2000;23:695-700
69. Schwarz MI. Miscellaneous interstitial lung diseases. In: Schwarz MI, King TE Jr, eds. Interstitial Lung Disease. Hamilton, ON: BC Decker; 2003:877-916
70. Springmeyer SC, Hackman R, Carlson JJ, McClellan JE. Bronchioloalveolar cell carcinoma diagnosed by bronchoalveolar lavage. Chest 1983;83:278-279
71. Keicho N, Oka T, Takeuchi K, Yamane A, Yazaki Y, Yotsumoto H. Detection of lymphomatous involvement of the lung by bronchoalveolar lavage: application of immunophenotypic and gene rearrangement analysis. Chest 1994;105:458-462
72. Zompi S, Couderc LJ, Cadranel J, et al. Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphoma. Blood 2004;103:3208-3215
73. Tiroke AH, Bewig B, Haverich A. Bronchoalveolar lavage in lung transplantation. Clin Transplant 1999;13:131-157
74. Meyer KC. The role of neutrophils in transplantation. In: Wilkes DS, Burlingham WJ, eds. Immunobiology of Organ Transplantation. New York: Kluwer/Plenum; 2004:493-507
75. Meyer KC, Nunley DR, Dauber J, et al. Neutrophils, unopposed neutrophil elastase and alpha-1-antiprotease defenses following human lung transplantation. Am J Respir Crit Care Med 2001;164:97-102
76. Bowdish ME, Arcasoy SM, Wilt JS, et al. Surrogate markers and risk factors for chronic lung allograft dysfunction. Am J Transplant 2004;4:1171-1178
77. Lu BS, Yu AD, Zhu X, Garrity ER Jr, Vigneswaran WT, Bhorade SM. Sequential gene expression profiling in lung transplant recipients with chronic rejection. Chest 2006;130: 847-854
78. Zhang Y, Wroblewski M, Hertz MI, Wendt CH, Cervenka TM, Nelsestuen GL. Analysis of chronic lung transplant rejection by MALDI-TOF profiles of bronchoalveolar lavage fluid. Proteomics 2006;6:1001-1010
79. Gimino VJ, Lande JD, Berryman TR, King RA, Hertz ML Gene expression profiling of bronchoalveolar lavage cells in acute lung rejection. Am J Respir Crit Care Med 2003;168: 1237-1242
80. Valentine VG, Taylor DE, Dhillon GS, et al. Success of lung transplantation without surveillance bronchoscopy. J Heart Lung Transplant 2002;21:319-326
81. Palmer SM, Miralles AP, Howell DN, et al. Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest 2000;118:1214-1217
82. Farrell S, McMaster C, Gibson D, Shields MD, McCallion WA. Pepsin in bronchoalveolar lavage fluid: a specific and sensitive method of diagnosing gastro-oesophageal reflux-related pulmonary aspiration. J Pediatr Surg 2006;41:289-293
83. Ratjen F, Bredendick M, Brendel M, et al. Differential cytology of bronchoalveolar lavage fluid in normal children. Eur Respir J 1994;7:1865-1870
84. Ratjen F, Bredendick M, Zheng L, et al. Lymphocyte subsets in bronchoalveolar lavage fluid of children without bronchopulmonary disease. Am J Respir Crit Care Med 1995;152: 174-178
85. Midulla F, Villani A, Merolla R, et al. Bronchoalveolar lavage studies in children without parenchymal lung disease: cellular constituents and protein levels. Pediatr Pulmonol 1995;20:112-118
86. Ratjen F, Bruch J. Adjustment of bronchoalveolar lavage volume to body weight in children. Pediatr Pulmonol 1996;21:184-188
87. Fan LL, Lum Lung MC, Wagener JS. The diagnostic value of bronchoalveolar lavage in immunocompetent children with chronic diffuse pulmonary infiltrates. Pediatr Pulmonol 1997;23:8-13
88. Colombo JL, Hallberg TK. Recurrent aspiration in children: lipid-laden alveolar macrophage quantitation. Pediatr Pulmonol 1987;3:86-89
89. Ahrens P, Noll C, Kitz R, et al. Lipid-laden alveolar macrophages (LLAM): a useful marker of silent aspiration in children. Pediatr Pulmonol 1999;28:83-88
90. Bauer ML, Lyrene RK. Chronic aspiration in children: evaluation of the lipid-laden macrophage index. Pediatr Pulmonol 1999;28:94-100
91. Chang AB, Cox NC, Purcell J, et al. Airway cellularity, lipid laden macrophages and microbiology of gastric juice and airways in children with reflux oesophagitis. Respir Res 2005;15:72
92. Meyer KC, Sharma A. Regional lung inflammation in cystic fibrosis. Am J Respir Crit Care Med 1997;156:1536-1540
93. Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994;150:448-454
94. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995;151: 1075-1082
95. Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, Phelan PD. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ 1995;310:1571-1572
96. Rosenfeld M, Gibson R, McNamara S, et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 2001;32: 356-366
97. Rosenfeld M, Emerson J, Accurso F, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999;28:321-328
98. Baughman RP, Keeton D, Perez C, Wilmott R. Use of bronchoalveolar lavage semiquantitative cultures in cystic fibrosis. Am J Respir Crit Care Med 1997;156:286-291
99. Hilliard TN, Sukhani S, Francis J, et al. Bronchoscopy following diagnosis with Cystic Fibrosis. Arch Dis Child 2007;92:898-899
100. Wainwright C. Bronchoalveolar lavage to guide management of lung disease in children with cystic fibrosis. Pediatr Pulmonol 2006;29(Suppl):188-189
101. Agostini C, Miorin M, Semenzato G. Gene expression profile analysis by DNA microarrays: a new approach to assess functional genomics in diseases. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:5-9
102. Kaminski N, Rosas IO. Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes? Proc Am Thorac Soc 2006;3:339-344
103. Bowler RP, Ellison MC, Reisdorph N. Proteomics in pulmonary medicine. Chest 2006;130:567-574
104. Lenz AG, Meyer B, Costabel U, Maier K. Bronchoalveolar lavage fluid proteins in human lung disease: analysis by two-dimensional electrophoresis. Electrophoresis 1993;14:242-244
105. Uebelhoer M, Bewig B, Oldigs M, et al. Protein profile in bronchoalveolar lavage fluid from patients with sarcoidosis and idiopathic pulmonary fibrosis as revealed by SDS-PAGE electrophoresis and western blot analysis. Scand J Clin Lab Invest 1993;53:617-623
106. Wattiez R, Hermans C, Cruyt C, Bernard A, Falmagne P. Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Electrophoresis 2000;21:2703-2712
107. Magi B, Bini L, Perari MG, et al. Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study. Electrophoresis 2002;23:3434-3444
108. Rottoli P, Magi B, Perari MG, et al. Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 2005;5:1423-1430
109. Sabounchi-Schütt F, Mikko M, Eklund A, Grunewald J, Aström J. Serum protein pattern in sarcoidosis analysed by a proteomics approach. Sarcoidosis Vasc Diffuse Lung Dis 2004;21:182-190
110. de Torre C, Ying S, Munson PJ, Meduri GU, Suffredini AF. Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics 2006;6:3949-3957
111. Cosgrove GP, Brown KK, Schiemann WP, et al. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am J Respir Crit Care Med 2004;170:242-251
112. Zuo F, Kaminski N, Eugui E, et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA 2002;99:6292-6297
113. Pardo A, Gibson K, Cisneros J, et al. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med 2005;2:e251
114. Thonhofer R, Maercker C, Popper HH. Expression of sarcoidosis related genes in lung lavage cells. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:59-65
115. Selman M, Pardo A, Barrera L, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006;173:188-198
116. Rutherford RM, Kehren J, Staedtler F, et al. Functional genomics in sarcoidosis: reduced or increased apoptosis? Swiss Med Wkly 2001;131:459-470
117. Rutherford RM, Staedtler F, Kehren J, et al. Functional genomics and prognosis in sarcoidosis: the critical role of antigen presentation. Sarcoidosis Vasc Diffuse Lung Dis 2004;21:10-18
118. Kadota J, Mizunoe S, Mito K, et al. High plasma concentrations of osteopontin in patients with interstitial pneumonia. Respir Med 2005;99:111-117